|
1
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Howson CP, Hiyama T and Wynder EL: The
decline in gastric cancer: Epidemiology of an unplanned triumph.
Epidemiol Rev. 8:1–27. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sepulveda AR: Helicobacter, Inflammation,
and Gastric Cancer. Curr Pathobiol Rep. 1:9–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yakirevich E and Resnick MB: Pathology of
gastric cancer and its precursor lesions. Gastroenterol Clin North
Am. 42:261–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kluijt I, Siemerink EJ, Ausems MG, van Os
TA, de Jong D, Simões-Correia J, van Krieken JH, Ligtenberg MJ,
Figueiredo J, van Riel E, et al: CDH1-related hereditary diffuse
gastric cancer syndrome: Clinical variations and implications for
counseling. Int J Cancer. 131:367–376. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Humar B, Blair V, Charlton A, More H,
Martin I and Guilford P: E-cadherin deficiency initiates gastric
signet-ring cell carcinoma in mice and man. Cancer Res.
69:2050–2056. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oliveira C, Sousa S, Pinheiro H, Karam R,
Bordeira-Carrico R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmão
L, et al: Quantification of epigenetic and genetic 2nd hits in CDH1
during hereditary diffuse gastric cancer syndrome progression.
Gastroenterology. 136:2137–2148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakayama S, Sasaki A, Mese H, Alcalde RE,
Tsuji T and Matsumura T: The E-cadherin gene is silenced by CpG
methylation in human oral squamous cell carcinomas. Int J Cancer.
93:667–673. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brooks-Wilson AR, Kaurah P, Suriano G,
Leach S, Senz J, Grehan N, Butterfield YS, Jeyes J, Schinas J,
Bacani J, et al: Germline E-cadherin mutations in hereditary
diffuse gastric cancer: Assessment of 42 new families and review of
genetic screening criteria. J Med Genet. 41:508–517. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Molinaro V, Pensotti V, Marabelli M,
Feroce I, Barile M, Pozzi S, Laghi L, Serrano D, Bernard L, Bonanni
B and Ranzani GN: Complementary molecular approaches reveal
heterogeneous CDH1 germline defects in Italian patients with
hereditary diffuse gastric cancer (HDGC) syndrome. Genes
Chromosomes Cancer. 53:432–445. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pharoah PD, Guilford P and Caldas C:
International Gastric Cancer Linkage Consortium: Incidence of
gastric cancer and breast cancer in CDH1 (E-cadherin) mutation
carriers from hereditary diffuse gastric cancer families.
Gastroenterology. 121:1348–1353. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kaurah P, MacMillan A, Boyd N, Senz J, De
Luca A, Chun N, Suriano G, Zaor S, Van Manen L, Gilpin C, et al:
Founder and recurrent CDH1 mutations in families with hereditary
diffuse gastric cancer. JAMA. 297:2360–2372. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shah MA, Salo-Mullen E, Stadler Z, Ruggeri
JM, Mirander M, Pristyazhnyuk Y and Zhang L: De novo CDH1 mutation
in a family presenting with early-onset diffuse gastric cancer.
Clin Genet. 82:283–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salmon A, Amikam D, Sodha N, Davidson S,
Basel-Vanagaite L, Eeles RA, Abeliovich D and Peretz T: Rapid
development of post-radiotherapy sarcoma and breast cancer in a
patient with a novel germline ‘de-novo’ TP53 mutation. Clin Oncol
(R Coll Radiol). 19:490–493. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
McVeigh TP, Choi JK, Miller NM, Green AJ
and Kerin MJ: Lobular breast cancer in a CDH1 splice site mutation
carrier: Case report and review of the literature. Clin Breast
Cancer. 14:e47–e51. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Corso G, Figueiredo J, Biffi R, Trentin C,
Bonanni B, Feroce I, Serrano D, Cassano E, Annibale B, Melo S, et
al: E-cadherin germline mutation carriers: Clinical management and
genetic implications. Cancer Metastasis Rev. 33:1081–1094. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan VP and Wong BC: Gastric cancer
chemoprevention: The current evidence. Gastroenterol Clin North Am.
42:299–316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yadav SK, Sah AK, Jha RK, Sah P and Shah
DK: Turmeric (curcumin) remedies gastroprotective action.
Pharmacogn Rev. 7:42–46. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yatsuya H, Toyoshima H, Mizoue T, Kondo T,
Tamakoshi K, Hori Y, Tokui N, Hoshiyama Y, Kikuchi S, Sakata K, et
al: Family history and the risk of stomach cancer death in Japan:
Differences by age and gender. Int J Cancer. 97:688–694. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han MA, Oh MG, Choi IJ, Park SR, Ryu KW,
Nam BH, Cho SJ, Kim CG, Lee JH and Kim YW: Association of family
history with cancer recurrence and survival in patients with
gastric cancer. J Clin Oncol. 30:701–708. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van der Post RS, Vogelaar IP, Manders P,
van der Kolk LE, Cats A, van Hest LP, Sijmons R, Aalfs CM, Ausems
MG, Gómez Garcia EB, et al: Accuracy of hereditary diffuse gastric
cancer testing criteria and outcomes in patients with a germline
mutation in CDH1. Gastroenterology. 149:897–906.e19. 2015.
View Article : Google Scholar : PubMed/NCBI
|
